CLINICAL_TRIALS
trial_result
· 2021-05-27
Clinical Trial Update: Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis [Phase 2]
Summary
Phase 2 trial update on safety and tolerability of AIN457 in adults with psoriatic arthritis, with results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Psoriatic Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2021-05-27